Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009
Published online before print October 8, 2009, doi: 10.1161/CIRCRESAHA.109.200303
A more recent version of this article appeared on November 20, 2009
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
105/11/1102    most recent
CIRCRESAHA.109.200303v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ma, X.
Right arrow Articles by Wei, Q.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, X.
Right arrow Articles by Wei, Q.
Related Collections
Right arrow Animal models of human disease
Right arrow Myocardial cardiomyopathy disease
Right arrow Cardiac development

Submitted on December 8, 2008
Revised on September 17, 2009
Accepted on September 24, 2009

Conditional Ablation of Nonmuscle Myosin II-B Delineates Heart Defects in Adult Mice

Xuefei Ma ; Kazuyo Takeda ; Aman Singh ; Zu-Xi Yu ; Patricia Zerfas ; Anthony Blount ; Chengyu Liu ; Jeffrey A. Towbin ; Michael D. Schneider ; Robert S. Adelstein *; and Qize Wei

From the Laboratory of Molecular Cardiology (X.M., K.T., A.S., A.B., R.S.A., Q.W.), Pathology Core Facility (Z.-X.Y.), and Transgenic Mouse Core Facility (C.L.), National Heart, Lung, and Blood Institute; and Division of Veterinary Resources (P.Z.), NIH, Bethesda, Md; Cincinnati Children's Hospital Medical Center (J.A.T.), Ohio; and National Heart and Lung Institute (M.D.S.), Imperial College, London, United Kingdom.

* To whom correspondence should be addressed. E-mail: adelster{at}mail.nih.gov.

Rationale: Germline ablation of the cytoskeletal protein nonmuscle myosin (NM)II-B results in embryonic lethality, with defects in both the brain and heart. Tissue-specific ablation of NMII-B by a Cre recombinase strategy should prevent embryonic lethality and permit study of the function of NMII-B in adult hearts.

Objective: We sought to understand the function of NMII-B in adult mouse hearts and to see whether the brain defects found in germline-ablated mice influence cardiac development.

Methods and Results: We used a loxP/Cre recombinase strategy to specifically ablate NMII-B in the brains or hearts of mice. Mice ablated for NMII-B in neural tissues die between postnatal day 12 and 22 without showing cardiac defects. Mice deficient in NMII-B only in cardiac myocytes (B{alpha}MHC/B{alpha}MHC mice) do not show brain defects. However, B{alpha}MHC/B{alpha}MHC mice display novel cardiac defects not seen in NMII-B germline-ablated mice. Most of the B{alpha}MHC/B{alpha}MHC mice are born with enlarged cardiac myocytes, some of which are multinucleated, reflecting a defect in cytokinesis. Between 6 to 10 months, they develop a cardiomyopathy that includes interstitial fibrosis and infiltration of the myocardium and pericardium with inflammatory cells. Four of 5 B{alpha}MHC/B{alpha}MHC hearts develop marked widening of intercalated discs.

Conclusions: By avoiding the embryonic lethality found in germline-ablated mice, we were able to study the function of NMII-B in adult mice and show that absence of NMII-B in cardiac myocytes results in cardiomyopathy in the adult heart. We also define a role for NMII-B in maintaining the integrity of intercalated discs.


Key words: nonmuscle myosin II-B • cardiomyopathy • intercalated discs